Removal of JMA, JPA Members from OTC Drug Review Council, Open Discussion Would Be Difficult, Says JMA Exec

A member of the health ministry’s council to review over-the-counter (OTC) drugs said on October 7 that it would be difficult to remove members of the Japan Medical Association (JMA), Japan Pharmaceutical Association (JPA), and other vested interest healthcare groups...read more